CLINICAL24 sets the stage for global discussion around lab medicine
Brand new event designed to bring together everyone working in the clinical laboratory science industry
Brand new event designed to bring together everyone working in the clinical laboratory science industry
Understand the importance of fostering cross-department collaboration for an optimal antimicrobial stewardship program
From the manufacture and supply of raw materials to risk mitigation and assay development capabilities, learn how Merck is helping IVD developers bring new devices to market
Explore the modern point-of-care ecosystem and its impact on healthcare delivery
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
An introduction to the challenges and considerations for clinical labs embarking on digital transformation in healthcare
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways
SelectScience clinical webinars can be added to HCPC and IBMS portfolios as evidence of CPD
Discover how modern quality control (QC) principles can enhance operational efficiency and healthcare outcomes
The new platform promises to substantially lower hands-on time, allowing for increased lab productivity
The new diagnostic system, which combines optofluidics and nanopores can test for COVID-19 and Zika virus
A study suggests that a subtype of Fusobacterium nucleatum underlies colorectal cancer growth in humans and could be useful in screening and treatments
Discover the human side of laboratory medicine with our #Lab4Life editorial feature
Annual ECCMID congress is now ESCMID Global
The analyzer can now function with new CE-Marked Hepatitis assays announced at ESCMID Global
Smartphone-sized laboratory – Sepsis IVD grade test based on cutting-edge BioMEMS technology is a joint development objective
This is the first four-in-one nucleic acid test for arbovirus screening
Point-of-care HIV diagnostic testing for infants and early detection of HIV infections
The cobas Malaria test is the first FDA-approved molecular test to screen US blood donors for malaria
The respiratory/sore throat (R/ST) panel receives Dual 510(k) clearance and CLIA-waiver approval
The Selux PBC Separator, part of the Next Generation Phenotyping (NGP) System, makes this the only FDA cleared, single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies
David Wells, CEO of the IBMS, discusses the Institute’s plans to ensure the future of biomedical science careers
Experts discuss the game-changing potential of novel host response-based diagnostics to combat the global challenge of antimicrobial resistance (AMR)
Portable testing platforms are set to drive precision medicine and community health into 2024, so when will they see a more widespread adoption amongst healthcare providers and individuals alike?
Could stronger collaboration from lab-to-frontline care be the key to advancing antimicrobial stewardship (AMS)?